Immune Anti-Inhibitor Market, Global Outlook and Forecast 2022-2028

March 2022 | 73 pages | ID: IFAA7388FF6EEN
Market Monitor Global

Abstracts

Immune inhibitors are associated with haemophilia and inhibitors are antibodies developed in haemophilia patients. Haemophilia is a hereditary bleeding disorder, which occurs due to deficiency or absence of clotting factor VIII (haemophilia A) or clotting factor IX (haemophilia B).

This report contains market size and forecasts of Immune Anti-Inhibitor in global, including the following market information:

Global Immune Anti-Inhibitor Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Immune Anti-Inhibitor Market Sales, 2017-2022, 2023-2028, (K Pieces)

Global top five Immune Anti-Inhibitor companies in 2021 (%)

The global Immune Anti-Inhibitor market was valued at 10180 million in 2021 and is projected to reach US$ 15730 million by 2028, at a CAGR of 6.4% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Recombinant Immune Anti-Inhibitor Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Immune Anti-Inhibitor include Shire, Baxter, Roche, Novo Nordisk and CSL, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Immune Anti-Inhibitor manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Immune Anti-Inhibitor Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pieces)

Global Immune Anti-Inhibitor Market Segment Percentages, by Type, 2021 (%)

• Recombinant Immune Anti-Inhibitor
• Plasma-derived Immune Anti-Inhibitor
• Others

Global Immune Anti-Inhibitor Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pieces)

Global Immune Anti-Inhibitor Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacies
• Online Pharmacies
• Retail Pharmacies

Global Immune Anti-Inhibitor Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pieces)

Global Immune Anti-Inhibitor Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Immune Anti-Inhibitor revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Immune Anti-Inhibitor revenues share in global market, 2021 (%)

Key companies Immune Anti-Inhibitor sales in global market, 2017-2022 (Estimated), (K Pieces)

Key companies Immune Anti-Inhibitor sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Shire
• Baxter
• Roche
• Novo Nordisk
• CSL

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Immune Anti-Inhibitor Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Immune Anti-Inhibitor Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL IMMUNE ANTI-INHIBITOR OVERALL MARKET SIZE

2.1 Global Immune Anti-Inhibitor Market Size: 2021 VS 2028
2.2 Global Immune Anti-Inhibitor Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Immune Anti-Inhibitor Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Immune Anti-Inhibitor Players in Global Market
3.2 Top Global Immune Anti-Inhibitor Companies Ranked by Revenue
3.3 Global Immune Anti-Inhibitor Revenue by Companies
3.4 Global Immune Anti-Inhibitor Sales by Companies
3.5 Global Immune Anti-Inhibitor Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Immune Anti-Inhibitor Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Immune Anti-Inhibitor Product Type
3.8 Tier 1, Tier 2 and Tier 3 Immune Anti-Inhibitor Players in Global Market
  3.8.1 List of Global Tier 1 Immune Anti-Inhibitor Companies
  3.8.2 List of Global Tier 2 and Tier 3 Immune Anti-Inhibitor Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Immune Anti-Inhibitor Market Size Markets, 2021 & 2028
  4.1.2 Recombinant Immune Anti-Inhibitor
  4.1.3 Plasma-derived Immune Anti-Inhibitor
  4.1.4 Others
4.2 By Type - Global Immune Anti-Inhibitor Revenue & Forecasts
  4.2.1 By Type - Global Immune Anti-Inhibitor Revenue, 2017-2022
  4.2.2 By Type - Global Immune Anti-Inhibitor Revenue, 2023-2028
  4.2.3 By Type - Global Immune Anti-Inhibitor Revenue Market Share, 2017-2028
4.3 By Type - Global Immune Anti-Inhibitor Sales & Forecasts
  4.3.1 By Type - Global Immune Anti-Inhibitor Sales, 2017-2022
  4.3.2 By Type - Global Immune Anti-Inhibitor Sales, 2023-2028
  4.3.3 By Type - Global Immune Anti-Inhibitor Sales Market Share, 2017-2028
4.4 By Type - Global Immune Anti-Inhibitor Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Immune Anti-Inhibitor Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacies
  5.1.3 Online Pharmacies
  5.1.4 Retail Pharmacies
5.2 By Application - Global Immune Anti-Inhibitor Revenue & Forecasts
  5.2.1 By Application - Global Immune Anti-Inhibitor Revenue, 2017-2022
  5.2.2 By Application - Global Immune Anti-Inhibitor Revenue, 2023-2028
  5.2.3 By Application - Global Immune Anti-Inhibitor Revenue Market Share, 2017-2028
5.3 By Application - Global Immune Anti-Inhibitor Sales & Forecasts
  5.3.1 By Application - Global Immune Anti-Inhibitor Sales, 2017-2022
  5.3.2 By Application - Global Immune Anti-Inhibitor Sales, 2023-2028
  5.3.3 By Application - Global Immune Anti-Inhibitor Sales Market Share, 2017-2028
5.4 By Application - Global Immune Anti-Inhibitor Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Immune Anti-Inhibitor Market Size, 2021 & 2028
6.2 By Region - Global Immune Anti-Inhibitor Revenue & Forecasts
  6.2.1 By Region - Global Immune Anti-Inhibitor Revenue, 2017-2022
  6.2.2 By Region - Global Immune Anti-Inhibitor Revenue, 2023-2028
  6.2.3 By Region - Global Immune Anti-Inhibitor Revenue Market Share, 2017-2028
6.3 By Region - Global Immune Anti-Inhibitor Sales & Forecasts
  6.3.1 By Region - Global Immune Anti-Inhibitor Sales, 2017-2022
  6.3.2 By Region - Global Immune Anti-Inhibitor Sales, 2023-2028
  6.3.3 By Region - Global Immune Anti-Inhibitor Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Immune Anti-Inhibitor Revenue, 2017-2028
  6.4.2 By Country - North America Immune Anti-Inhibitor Sales, 2017-2028
  6.4.3 US Immune Anti-Inhibitor Market Size, 2017-2028
  6.4.4 Canada Immune Anti-Inhibitor Market Size, 2017-2028
  6.4.5 Mexico Immune Anti-Inhibitor Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Immune Anti-Inhibitor Revenue, 2017-2028
  6.5.2 By Country - Europe Immune Anti-Inhibitor Sales, 2017-2028
  6.5.3 Germany Immune Anti-Inhibitor Market Size, 2017-2028
  6.5.4 France Immune Anti-Inhibitor Market Size, 2017-2028
  6.5.5 U.K. Immune Anti-Inhibitor Market Size, 2017-2028
  6.5.6 Italy Immune Anti-Inhibitor Market Size, 2017-2028
  6.5.7 Russia Immune Anti-Inhibitor Market Size, 2017-2028
  6.5.8 Nordic Countries Immune Anti-Inhibitor Market Size, 2017-2028
  6.5.9 Benelux Immune Anti-Inhibitor Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Immune Anti-Inhibitor Revenue, 2017-2028
  6.6.2 By Region - Asia Immune Anti-Inhibitor Sales, 2017-2028
  6.6.3 China Immune Anti-Inhibitor Market Size, 2017-2028
  6.6.4 Japan Immune Anti-Inhibitor Market Size, 2017-2028
  6.6.5 South Korea Immune Anti-Inhibitor Market Size, 2017-2028
  6.6.6 Southeast Asia Immune Anti-Inhibitor Market Size, 2017-2028
  6.6.7 India Immune Anti-Inhibitor Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Immune Anti-Inhibitor Revenue, 2017-2028
  6.7.2 By Country - South America Immune Anti-Inhibitor Sales, 2017-2028
  6.7.3 Brazil Immune Anti-Inhibitor Market Size, 2017-2028
  6.7.4 Argentina Immune Anti-Inhibitor Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Immune Anti-Inhibitor Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Immune Anti-Inhibitor Sales, 2017-2028
  6.8.3 Turkey Immune Anti-Inhibitor Market Size, 2017-2028
  6.8.4 Israel Immune Anti-Inhibitor Market Size, 2017-2028
  6.8.5 Saudi Arabia Immune Anti-Inhibitor Market Size, 2017-2028
  6.8.6 UAE Immune Anti-Inhibitor Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Shire
  7.1.1 Shire Corporate Summary
  7.1.2 Shire Business Overview
  7.1.3 Shire Immune Anti-Inhibitor Major Product Offerings
  7.1.4 Shire Immune Anti-Inhibitor Sales and Revenue in Global (2017-2022)
  7.1.5 Shire Key News
7.2 Baxter
  7.2.1 Baxter Corporate Summary
  7.2.2 Baxter Business Overview
  7.2.3 Baxter Immune Anti-Inhibitor Major Product Offerings
  7.2.4 Baxter Immune Anti-Inhibitor Sales and Revenue in Global (2017-2022)
  7.2.5 Baxter Key News
7.3 Roche
  7.3.1 Roche Corporate Summary
  7.3.2 Roche Business Overview
  7.3.3 Roche Immune Anti-Inhibitor Major Product Offerings
  7.3.4 Roche Immune Anti-Inhibitor Sales and Revenue in Global (2017-2022)
  7.3.5 Roche Key News
7.4 Novo Nordisk
  7.4.1 Novo Nordisk Corporate Summary
  7.4.2 Novo Nordisk Business Overview
  7.4.3 Novo Nordisk Immune Anti-Inhibitor Major Product Offerings
  7.4.4 Novo Nordisk Immune Anti-Inhibitor Sales and Revenue in Global (2017-2022)
  7.4.5 Novo Nordisk Key News
7.5 CSL
  7.5.1 CSL Corporate Summary
  7.5.2 CSL Business Overview
  7.5.3 CSL Immune Anti-Inhibitor Major Product Offerings
  7.5.4 CSL Immune Anti-Inhibitor Sales and Revenue in Global (2017-2022)
  7.5.5 CSL Key News

8 GLOBAL IMMUNE ANTI-INHIBITOR PRODUCTION CAPACITY, ANALYSIS

8.1 Global Immune Anti-Inhibitor Production Capacity, 2017-2028
8.2 Immune Anti-Inhibitor Production Capacity of Key Manufacturers in Global Market
8.3 Global Immune Anti-Inhibitor Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 IMMUNE ANTI-INHIBITOR SUPPLY CHAIN ANALYSIS

10.1 Immune Anti-Inhibitor Industry Value Chain
10.2 Immune Anti-Inhibitor Upstream Market
10.3 Immune Anti-Inhibitor Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Immune Anti-Inhibitor Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Immune Anti-Inhibitor in Global Market
Table 2. Top Immune Anti-Inhibitor Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Immune Anti-Inhibitor Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Immune Anti-Inhibitor Revenue Share by Companies, 2017-2022
Table 5. Global Immune Anti-Inhibitor Sales by Companies, (K Pieces), 2017-2022
Table 6. Global Immune Anti-Inhibitor Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Immune Anti-Inhibitor Price (2017-2022) & (USD/Piece)
Table 8. Global Manufacturers Immune Anti-Inhibitor Product Type
Table 9. List of Global Tier 1 Immune Anti-Inhibitor Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Immune Anti-Inhibitor Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Immune Anti-Inhibitor Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Immune Anti-Inhibitor Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Immune Anti-Inhibitor Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Immune Anti-Inhibitor Sales (K Pieces), 2017-2022
Table 15. By Type - Global Immune Anti-Inhibitor Sales (K Pieces), 2023-2028
Table 16. By Application – Global Immune Anti-Inhibitor Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Immune Anti-Inhibitor Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Immune Anti-Inhibitor Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Immune Anti-Inhibitor Sales (K Pieces), 2017-2022
Table 20. By Application - Global Immune Anti-Inhibitor Sales (K Pieces), 2023-2028
Table 21. By Region – Global Immune Anti-Inhibitor Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Immune Anti-Inhibitor Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Immune Anti-Inhibitor Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Immune Anti-Inhibitor Sales (K Pieces), 2017-2022
Table 25. By Region - Global Immune Anti-Inhibitor Sales (K Pieces), 2023-2028
Table 26. By Country - North America Immune Anti-Inhibitor Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Immune Anti-Inhibitor Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Immune Anti-Inhibitor Sales, (K Pieces), 2017-2022
Table 29. By Country - North America Immune Anti-Inhibitor Sales, (K Pieces), 2023-2028
Table 30. By Country - Europe Immune Anti-Inhibitor Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Immune Anti-Inhibitor Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Immune Anti-Inhibitor Sales, (K Pieces), 2017-2022
Table 33. By Country - Europe Immune Anti-Inhibitor Sales, (K Pieces), 2023-2028
Table 34. By Region - Asia Immune Anti-Inhibitor Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Immune Anti-Inhibitor Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Immune Anti-Inhibitor Sales, (K Pieces), 2017-2022
Table 37. By Region - Asia Immune Anti-Inhibitor Sales, (K Pieces), 2023-2028
Table 38. By Country - South America Immune Anti-Inhibitor Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Immune Anti-Inhibitor Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Immune Anti-Inhibitor Sales, (K Pieces), 2017-2022
Table 41. By Country - South America Immune Anti-Inhibitor Sales, (K Pieces), 2023-2028
Table 42. By Country - Middle East & Africa Immune Anti-Inhibitor Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Immune Anti-Inhibitor Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Immune Anti-Inhibitor Sales, (K Pieces), 2017-2022
Table 45. By Country - Middle East & Africa Immune Anti-Inhibitor Sales, (K Pieces), 2023-2028
Table 46. Shire Corporate Summary
Table 47. Shire Immune Anti-Inhibitor Product Offerings
Table 48. Shire Immune Anti-Inhibitor Sales (K Pieces), Revenue (US$, Mn) and Average Price (USD/Piece) (2017-2022)
Table 49. Baxter Corporate Summary
Table 50. Baxter Immune Anti-Inhibitor Product Offerings
Table 51. Baxter Immune Anti-Inhibitor Sales (K Pieces), Revenue (US$, Mn) and Average Price (USD/Piece) (2017-2022)
Table 52. Roche Corporate Summary
Table 53. Roche Immune Anti-Inhibitor Product Offerings
Table 54. Roche Immune Anti-Inhibitor Sales (K Pieces), Revenue (US$, Mn) and Average Price (USD/Piece) (2017-2022)
Table 55. Novo Nordisk Corporate Summary
Table 56. Novo Nordisk Immune Anti-Inhibitor Product Offerings
Table 57. Novo Nordisk Immune Anti-Inhibitor Sales (K Pieces), Revenue (US$, Mn) and Average Price (USD/Piece) (2017-2022)
Table 58. CSL Corporate Summary
Table 59. CSL Immune Anti-Inhibitor Product Offerings
Table 60. CSL Immune Anti-Inhibitor Sales (K Pieces), Revenue (US$, Mn) and Average Price (USD/Piece) (2017-2022)
Table 61. Immune Anti-Inhibitor Production Capacity (K Pieces) of Key Manufacturers in Global Market, 2020-2022 (K Pieces)
Table 62. Global Immune Anti-Inhibitor Capacity Market Share of Key Manufacturers, 2020-2022
Table 63. Global Immune Anti-Inhibitor Production by Region, 2017-2022 (K Pieces)
Table 64. Global Immune Anti-Inhibitor Production by Region, 2023-2028 (K Pieces)
Table 65. Immune Anti-Inhibitor Market Opportunities & Trends in Global Market
Table 66. Immune Anti-Inhibitor Market Drivers in Global Market
Table 67. Immune Anti-Inhibitor Market Restraints in Global Market
Table 68. Immune Anti-Inhibitor Raw Materials
Table 69. Immune Anti-Inhibitor Raw Materials Suppliers in Global Market
Table 70. Typical Immune Anti-Inhibitor Downstream
Table 71. Immune Anti-Inhibitor Downstream Clients in Global Market
Table 72. Immune Anti-Inhibitor Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Immune Anti-Inhibitor Segment by Type
Figure 2. Immune Anti-Inhibitor Segment by Application
Figure 3. Global Immune Anti-Inhibitor Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Immune Anti-Inhibitor Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Immune Anti-Inhibitor Revenue, 2017-2028 (US$, Mn)
Figure 7. Immune Anti-Inhibitor Sales in Global Market: 2017-2028 (K Pieces)
Figure 8. The Top 3 and 5 Players Market Share by Immune Anti-Inhibitor Revenue in 2021
Figure 9. By Type - Global Immune Anti-Inhibitor Sales Market Share, 2017-2028
Figure 10. By Type - Global Immune Anti-Inhibitor Revenue Market Share, 2017-2028
Figure 11. By Type - Global Immune Anti-Inhibitor Price (USD/Piece), 2017-2028
Figure 12. By Application - Global Immune Anti-Inhibitor Sales Market Share, 2017-2028
Figure 13. By Application - Global Immune Anti-Inhibitor Revenue Market Share, 2017-2028
Figure 14. By Application - Global Immune Anti-Inhibitor Price (USD/Piece), 2017-2028
Figure 15. By Region - Global Immune Anti-Inhibitor Sales Market Share, 2017-2028
Figure 16. By Region - Global Immune Anti-Inhibitor Revenue Market Share, 2017-2028
Figure 17. By Country - North America Immune Anti-Inhibitor Revenue Market Share, 2017-2028
Figure 18. By Country - North America Immune Anti-Inhibitor Sales Market Share, 2017-2028
Figure 19. US Immune Anti-Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Immune Anti-Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Immune Anti-Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Immune Anti-Inhibitor Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Immune Anti-Inhibitor Sales Market Share, 2017-2028
Figure 24. Germany Immune Anti-Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 25. France Immune Anti-Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Immune Anti-Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Immune Anti-Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Immune Anti-Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Immune Anti-Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Immune Anti-Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Immune Anti-Inhibitor Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Immune Anti-Inhibitor Sales Market Share, 2017-2028
Figure 33. China Immune Anti-Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Immune Anti-Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Immune Anti-Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Immune Anti-Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 37. India Immune Anti-Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Immune Anti-Inhibitor Revenue Market Share, 2017-2028
Figure 39. By Country - South America Immune Anti-Inhibitor Sales Market Share, 2017-2028
Figure 40. Brazil Immune Anti-Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Immune Anti-Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Immune Anti-Inhibitor Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Immune Anti-Inhibitor Sales Market Share, 2017-2028
Figure 44. Turkey Immune Anti-Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Immune Anti-Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Immune Anti-Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Immune Anti-Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 48. Global Immune Anti-Inhibitor Production Capacity (K Pieces), 2017-2028
Figure 49. The Percentage of Production Immune Anti-Inhibitor by Region, 2021 VS 2028
Figure 50. Immune Anti-Inhibitor Industry Value Chain
Figure 51. Marketing Channels